Csilla Kriston
Budapest, BU, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Investigation of CD49f expression in childhood and adult B-cell acute lymphoblastic leukemia
Journal: Orvosi hetilap
Published: September 09, 2025
CD86, the double agent: Significance of CD86 expression in B-cell malignancies.
Journal: International journal of cancer
Published: March 21, 2025
Case Report: Flow cytometric differential diagnosis of a peripheral T-cell lymphoma, NOS with complete loss of CD45 and dim expression of CD3.
Journal: Pathology oncology research : POR
Published: January 29, 2025
Investigating the effect of immunomagnetic separation on the immunophenotype and viability of plasma cells in plasma cell disorders.
Journal: Pathology oncology research : POR
Published: June 18, 2024
The significance of CD49f expression in pediatric B-cell acute lymphoblastic leukemia.
Journal: American journal of clinical pathology
Published: January 25, 2024
Lenalidomide abrogates the survival effect of bone marrow stromal cells in chronic lymphocytic leukemia.
Journal: Hematological oncology
Published: January 26, 2021
Promoter Hypomethylation and Increased Expression of the Long Non-coding RNA LINC00152 Support Colorectal Carcinogenesis.
Journal: Pathology oncology research : POR
Published: September 18, 2019
Discrepancy Between Low Levels of mTOR Activity and High Levels of P-S6 in Primary Central Nervous System Lymphoma May Be Explained by PAS Domain-Containing Serine/Threonine-Protein Kinase-Mediated Phosphorylation.
Journal: Journal of neuropathology and experimental neurology
Published: January 24, 2018
In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment.
Journal: Annals of hematology
Published: November 21, 2017
Versatility of microglial bioenergetic machinery under starving conditions.
Journal: Biochimica et biophysica acta. Bioenergetics
Published: September 05, 2017
Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 17, 2017
The effect of microenvironmental factors on the development of myeloma cells.
Journal: Hematological oncology
Published: August 03, 2016
Last Updated: 09/26/2026